001630.KS
Chong Kun Dang Holdings Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 38,900.00
−0.51%Margins
Gross margin
41.6%
EBITDA margin
0.6%
EBIT margin
5.8%
Net margin
5.6%
FCF margin
1.1%
8.2%
Return on equity
3.1%
Return on assets
4.5%
Return on invested capital
0.56x
Asset turnover
KRW 99.2B
Cash from operations
KRW 49.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026